Capabilities

Patent Transaction

Complete Genomics

Our attorneys won a California federal court order granting summary judgment invalidating all of Illimina Inc’s asserted DNA sequencing method claims from US Patent No. 6,306,597 on behalf of Complete Genomics, a company that is furthering the DNA Sequencing-As-A-Service model.  In the summary judgment order, Judge Laporte accepted the argument our attorneys had been making all along, that in reducing his invention to practice the alleged inventor of the patent in the suit failed to exercise due diligence and that, therefore, a prior art publication invalidated all of the primary asserted method claims (Claim 1 and dependent Claims 9, 10, 14, 15, 16, 17, 18 and 19) of Illumina's '597 patent.

Email Disclaimer